Continuous Renal Replacement Therapy Market Size By Modality (Continuous Venovenous Hemofiltration, Continuous Venovenous Hemodiafiltration, Continuous Venovenous Hemodialysis, Slow Continuous Ultrafiltration), By Product (Instruments, Consumables), By Therapy (Renal, Non-renal) Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, France, UK, Italy, Spain, Russia, China, Japan, India, Australia, South Korea, Brazil, Mexico, Argentina, Saudi Arabia, South Africa, UAE), Application Potential, Competitive Market Share & Forecast, 2018 – 2024

Published Date: Nov 2018 | 160 Pages | Report ID: GMI2998 | Authors: Sumant Ugalmugale, Shradha Mupid Report Format: PDF

  Request Sample Inquiry Before Buying
Summary Table of Contents Industry Coverage Methodology Customize this Report

Industry Trends

Continuous Renal Replacement Therapy Market size was valued at USD 825 million in 2017 and is expected to witness 7.1% CAGR from 2018 to 2024.

U.S.Continuous Renal Replacement Therapy Market Size, By Modality, 2017 &2024 (USD Million)

U.S.Continuous Renal Replacement Therapy Market Size, By Modality, 2017 &2024 (USD Million)

Get more details on this report - Request Free Sample PDF

Increasing prevalence of acute kidney injuries will surge demand for continuous renal replacement therapies (CRRT) in foreseeable future. Acute kidney injury causes chronic renal disorders leading to severe loss of kidney function. According to NIDDK, around 14% of population in the U.S. suffers from renal disorders. Moreover, increasing per capita income and subsequent increase in healthcare expenditures will ensure availability of well-equipped public hospitals and critical care units thereby increasing continuous renal replacement therapy market growth. Moreover, increasing availability of technologically advanced CRRT systems ensuring fast recovery will further augment CRRT market growth.

Rising prevalence of diabetes in developing economies such as India and China leading to chronic kidney diseases and partial loss of kidney function will escalate the business growth over forthcoming years. According to FIRSTPOST, in 2017 almost 72 million Indians were detected with diabetes that will eventually affect kidney functioning. Lifestyle changes and unhealthy eating habits should further worsen the situation impacting industry growth. However, complications associated with the therapy may decrease its preference amongst geriatric population restraining continuous renal replacement therapy market growth during estimated forecast.

Continuous Renal Replacement Therapy Market, By Modality

Continuous venovenous hemodiafiltration (CVVHDF) segment accounted for 29.6% in 2017.  High revenue share is attributed to the preference for this modality amongst geriatric population owing to ease and convenience associated with it. The therapy is utilized in patients with multisystem organ failure or acute renal failure. CVVHDF is a slow continuous form of intermittent dialysis that enables quick patient recovery by maintaining electrolyte balance in the body.

Slow Continuous Ultrafiltration (SCUF) segment will witness 6.4% CAGR during the forecast timeframe. SCUF is mostly preferred by patients suffering from cardiac failure and blood pressure problems. There is a considerable reduction in the blood urea and creatinine levels after undergoing continuous slow ultrafiltration treatment. Increasing geriatric population in developed as well as developing economies that suffers from cardiac arrest due to kidney failure will boost segment growth over the upcoming years.

Continuous Renal Replacement Therapy Market, By Product

Instruments segment will experience robust 7.3% CAGR during forecast timeframe. The segmental growth is attributable to rising preference for CRRT. Major players focus their efforts on developing new technologically advanced CRRT system. These innovations introduced within the CRRT systems enable faster patient recovery and thus, increased adoption of these instruments enhancing segmental growth.

Consumables segment was valued at USD 500.7 million in 2017. CRRT involves use of consumables such as catheters and blood tube sets that are utilized in blood purification process. CRRT demands frequent replacement of consumables as reusing these consumables may lead to complications. High replacement rate coupled with increasing demand for CRRT therapies will augment the usage of consumables rendering positive impact on segment growth.

Germany Continuous Renal Replacement Market Size, By Product, 2017 (USD Million)

Germany Continuous Renal Replacement Market Size, By Product, 2017 (USD Million)

Get more details on this report - Request Free Sample PDF

Continuous Renal Replacement Therapy Market, By Therapy

Renal segment accounted for 79% revenue share and is expected to dominate the industry throughout forecast period. Renal therapies are utilized to treat patients experiencing kidney failure due to rapidly rising serum, urea and creatinine levels and severe metabolic acidosis. Availability of technologically advanced devices that are utilized in renal replacement therapies have ensured efficient removal of uremic toxins to maintain optimal salt levels. Aforementioned factors coupled with rising adult as well as neonatal population suffering from kidney failure will positively influence the business growth during forecast timeframe.

Non-renal segment was valued at USD 172.9 million in 2017 and enormous segmental growth can be attributed to the growing preference for non-renal treatments recently. Non-renal therapies are imparted to people suffering from partial kidney functioning for ingested toxins clearance, electrolyte abnormalities correction, temperature control and also in the treatment of chronic sepsis. According to Sepsis Alliance, around 26 million people globally are affected by sepsis every year that will augment the demand for non-renal therapy propelling segment growth during forecast timeframe.

Continuous Renal Replacement Therapy Market, By Region

U.S. continuous renal replacement therapy market will experience 7.4% CAGR during the forecast timeframe and increasing elderly population base will further enhance business growth in near future. Incidences of chronic kidney diseases and acute kidney injuries is high amongst the geriatric population. According to Kidney News, population in the age group of 65 years and above have high chances of acquiring end stage renal diseases (ESRD). Moreover, rising government initiatives that help in reducing the cost of therapies will positively influence CRRT industry growth

Japan continuous renal replacement therapy market was valued at USD 59.0 million and is expected to grow further due to rising prevalence of diabetes and obesity that interferes with normal kidney functioning. According to International Japanese Federation, there were around 7.2 billion people detected with diabetes in 2017. Majority of them suffer from loss of one or more kidney functions due to hormonal imbalance that affects the kidney functions. Aforementioned factors along with adoption of advanced technology by majority of industry players such as Toray based in Japan will enhance the business growth in forthcoming years.

Asia Pacific Continuous Renal Replacement Market Size, By Country, 2024 (USD Million)

Asia Pacific Continuous Renal Replacement Market Size, By Country, 2024 (USD Million)

Get more details on this report - Request Free Sample PDF

Competitive Market Share

Prominent industry players operational in the CRRT market include Asahi Kasei Corporation, B.Braun Melsungen, Baxter International, Fresenius Medical Care, Infomed, Medica, Medical Components, Medites, Medtronic, Nikkiso, Nxtstage, Toray. These manufacturers implement few strategies such as strategic mergers and acquisitions that render companies with competitive advantage. For instance, in October 2018, Baxter applied for U.S. regulatory filling for PrisMax Acute Care System. PrisMax CRRT system that is integrated with advanced technology and is designed to improve the accuracy and performance. Introduction of technologically advanced products by Baxter will enhance company’s revenue share.

Continuous Renal Replacement Therapy Industry Background

   Continuous Renal Replacement Therapy Market

Get more details on this report - Request Free Sample PDF

The evolution of CRRT market has been significant and can be traced back to 1997 with the introduction of continuous arterio-venous hemofiltration (CAVH) by Dr. Peter Kramer. Later in early 1990’s, automated machines for continuous renal replacement therapy were made available in clinics and intensive care units that enabled efficient and accurate treatment of patients suffering from accurate kidney injuries. Currently, nephrologists have high recommendation for CRRT, as the systems utilized in this therapy are technologically advanced and have high costs. Despite the high cost of CRRT systems, preference is high due to efficiency offered by them. Therefore, key leaders adopt certain strategic initiatives includes incorporation of innovative technology within CRRT systems that enables them in attaining sustainable profits. Moreover, CRRT market has numerous growth opportunities in future owing to favorable regulatory landscape that enables availability of superior quality CRRT devices for treatment.

What Information does this report contain?

Historical data coverage: 2013 to 2017; Growth Projections: 2018 to 2024.
Expert analysis: industry, governing, innovation and technological trends; factors impacting development; drawbacks, SWOT.
6-7 year performance forecasts: major segments covering applications, top products and geographies.
Competitive landscape reporting: market leaders and important players, competencies and capacities of these companies in terms of production as well as sustainability and prospects.

Our Market Research Reports Include:

  • Market snapshot
  • Market Segmentation
  • Value Chain Analysis
  • Growth Dynamics
  • Potential Market Opportunities
  • Regulatory Overview
  • Technology Evolution
  • Innovation & Sustainability

Why Global Market Insights?

 Comprehensive Research
  • All-inclusive coverage
  • In-depth and granular data (ex: information for 8 to 15 countries, with clients open to add to this list, in each report)
  • Penetrative insights & latest trends
  • Offers holistic understanding of the market
 Data Accuracy & Reliability
  • Unique methodology
  • Iterative in nature to eliminate errors
  • Detailed methodology, scope, assumptions and data sources available for reference
 Post-Sales Support
  • Committed to making a positive difference for our clients
  • Given the nature of this industry, we are committed to ensure that our clients get maximum return on their investment in our services
  • Every purchase comes with an option to obtain additional information:
    • up to 10% of the original cost
    • 45-minute analyst tele-call to obtain further clarity on the market.
 Security & Confidentiality
  • Global Market Insights, Inc. strictly adheres to PCI-DSS security norms.
  • Only PCI-DSS compliant payment methods used for highest level of client data security
This site is protected by Trustwave's Trusted Commerce program Authorize.Net Merchant - Click to Verify

Connect with our sales team

Chat With Us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info. I Agree